| Financial Year |
March 31 2023 |
| Monetary Funds |
274,095,954.39 |
| Held-for-trading Financial Assets |
323,374,519.78 |
| Notes Receivable |
-- |
| Accounts Receivable |
80,553,980.93 |
| Advances to Suppliers |
15,930,918.85 |
| Other Receivables |
2,512,086.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
249,611,998.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
55,409,722.20 |
| Other Current Assets |
2,558,383.38 |
| Total Current Assets |
1,004,243,473.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
276,036,148.13 |
| Under-construction Projects |
92,195,924.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,991,167.44 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
15,351,559.55 |
| Deferred Income Tax Assets |
17,076,618.85 |
| Other Non-Current Assets |
40,217,424.20 |
| Sub-Total of Non-Current Assets |
535,834,354.12 |
| Total Assets |
1,540,077,827.45 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
62,723,282.16 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,272,385.17 |
| Taxes Payable |
9,077,849.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,125,604.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,520,000.00 |
| Other Current Liabilities |
597,147.47 |
| Sub-Total of Current Liabilities |
108,004,620.72 |
| Long-term Loans |
13,235,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,786,080.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
49,947,167.84 |
| Total Liabilities |
157,951,788.56 |
| Paid-In Capital(Or Share Stock) |
407,330,500.00 |
| Capital Surplus |
349,280,439.72 |
| Surplus Reserve |
81,784,129.11 |
| LESS:Treasury Stock |
7,773,337.00 |
| Undistributed Profits |
529,880,599.22 |
| Minority Stockholder's Interest |
2,186,657.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,379,939,381.30 |
| Owner's Equity（Stockholder's Equity） |
1,382,126,038.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,540,077,827.45 |
